This report on the global veterinary therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global veterinary therapeutics market.
Browse Market Research Report @
Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic animal and zoonotic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Based on product type, the global veterinary therapeutics market has been segmented into drugs (anti-infectives, anti-inflammatory, parasiticides, and others), vaccines (inactivated vaccines, live attenuated vaccines, recombinant vaccines, and others), and feed additives (amino acids, antibiotics, and others). The market has been further studied from the point of view of major animal types. Based on animal type, the market has been categorized into companion animals and livestock animals. On the basis of route of administration, the market has been segmented into oral, parenteral, and topical. Based on distribution channel, the market has been segmented into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others.
Geographically, the global veterinary therapeutics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Australia, South Africa, Brazil, and Mexico. The report also profiles major players in the veterinary therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Merial Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc.
Fill the form for an exclusive sample of this report @
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.